Moffitt Notice of Blackbaud Data Incident. Learn More
Clinical Trials Search
Clinical Trial 18304
Cancer Type: Thoracic
Study Type: Treatment
NCT#: NCT02513563
Phase: Phase II
Prinicipal Investigator: Jhanelle Gray
Study Title
A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Summary
The purpose of this study is to find out what effects (good and bad) AZD1775 used in combination with carboplatin and paclitaxel will have on participants and their cancer.
Objective
Primary Objective: Determine the progression-free survival of carboplatin-paclitaxel plus AZD1775 in patients with advanced/metastatic SQCLC. Secondary Objectives: 1. Estimate time-to-event variables, such as overall survival time, duration of overall response, and duration of stable disease. 2. Estimate the disease control rates (complete response, partial response, and stable disease).
Therapies
Medications
AZD1775 (); MK-1775 (AZD1775); Paraplatin (carboplatin); Taxol (paclitaxel); carboplatin (); paclitaxel ()
>>>
>>>
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.